PREMIUM
Guidance on blood clots with Oxford/AstraZeneca vaccine in under 30s
Data suggests there is a higher risk of extremely rare blood clots following the first dose of the Oxford/AstraZeneca vaccine
This site is intended for Healthcare Professionals only
We and selected partners, use cookies or similar technologies as specified in the cookie policy and privacy policy.
You can consent to the use of such technologies by closing this notice.